Cambria Cannabis ETF (TOKE) Stock Analysis

Cambria Cannabis ETF (TOKE) Financial Services Profile

Cambria Cannabis ETF (TOKE) offers investors a diversified, global approach to investing in the cannabis industry, targeting a portfolio of 20 to 50 companies across various market caps. With a beta of 0.59, TOKE provides exposure to the cannabis market without dividend payouts.

What Is the Investment Thesis for TOKE?

Cambria Cannabis ETF (TOKE) presents an investment opportunity for those seeking exposure to the burgeoning global cannabis industry. With a market capitalization of $12.0M and a beta of 0.59, TOKE offers a relatively stable entry point into a volatile sector. The ETF's strategy of holding 20-50 cannabis companies worldwide provides diversification, mitigating single-stock risk. Growth catalysts include the ongoing legalization of cannabis in various jurisdictions globally, which is expected to drive increased demand and market expansion. However, potential risks include regulatory uncertainty and competition within the cannabis industry. The absence of dividend payouts means investors are relying solely on capital appreciation for returns.

Based on FMP financials and quantitative analysis

TOKE Key Highlights

Market Cap of $12.0M indicates a small-cap ETF focused on growth potential within the cannabis sector.

• Beta of 0.59 suggests lower volatility compared to the broader market, potentially appealing to risk-averse investors.
• Global exposure provides diversification across different regulatory environments and market dynamics within the cannabis industry.
• Targeting 20-50 companies allows for a focused approach on key players while maintaining diversification.
• Absence of dividend yield implies a focus on capital appreciation rather than income generation.

Who Are TOKE's Competitors?

TOKE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TOKE's Key Strengths?

Diversified exposure to the global cannabis industry.

• Relatively low beta compared to individual cannabis stocks.
• Targets companies across various market capitalizations.
• Actively managed portfolio.

What Are TOKE's Weaknesses?

Small market capitalization may limit liquidity.

• Dependent on the performance of the cannabis industry.
• Subject to regulatory risks and uncertainties.
• Absence of dividend yield.

What Could Drive TOKE Stock Higher?

Continued legalization of cannabis in various jurisdictions globally.

• Increasing acceptance of cannabis for medical and recreational use.
• Growth in the ancillary cannabis market, such as packaging and testing.
• Potential regulatory reforms that could benefit the cannabis industry.
• Increasing investment in cannabis research and development.

What Are the Key Risks for TOKE?

Regulatory changes that could negatively impact the cannabis industry.

• Competition from other cannabis ETFs and investment vehicles.
• Price volatility in the cannabis market.
• Negative sentiment towards the cannabis industry.
• Dependence on the performance of the cannabis industry.

What Are the Growth Opportunities for TOKE?

• Expansion into new geographic markets: As more countries and regions legalize cannabis, TOKE can expand its investment universe to include companies operating in these new markets. This geographic diversification can reduce risk and increase growth potential. The global cannabis market is projected to reach $57 billion by 2027, presenting a significant opportunity for TOKE to capture a larger share of the market. Timeline: Ongoing.
• Increased investment in ancillary cannabis businesses: TOKE can increase its exposure to companies that provide ancillary services to the cannabis industry, such as packaging, testing, and technology. These businesses often have higher margins and lower regulatory risks compared to cannabis cultivators and retailers. The ancillary cannabis market is expected to grow at a CAGR of 20% over the next five years. Timeline: Ongoing.
• Strategic partnerships with cannabis companies: TOKE can form strategic partnerships with leading cannabis companies to gain access to proprietary technology, distribution networks, or market insights. These partnerships can enhance the ETF's investment decision-making process and improve its overall performance. Partnerships can be formed immediately. Timeline: Ongoing.
• Development of new cannabis-focused investment products: Cambria can leverage its expertise in the cannabis market to develop new investment products, such as actively managed cannabis funds or thematic ETFs focused on specific segments of the industry. These new products can attract a wider range of investors and increase the company's assets under management. Thematic ETFs are gaining popularity, with assets under management growing by 30% annually. Timeline: Within 2-3 years.
• Lobbying and advocacy for cannabis legalization: TOKE can actively engage in lobbying and advocacy efforts to promote cannabis legalization and favorable regulatory policies. This can create a more favorable investment environment for cannabis companies and drive long-term growth for the industry. Legalization efforts are ongoing in various jurisdictions around the world. Timeline: Ongoing.

What Are TOKE's Competitive Advantages?

• Diversification across multiple cannabis companies.
• Global exposure to different regulatory environments.
• Expertise in identifying and analyzing cannabis companies.
• Established track record in managing cannabis-focused investments.

What Does TOKE Do?

Cambria Cannabis ETF (TOKE) is designed to provide investors with broad exposure to the global cannabis industry. Founded with the aim of capturing the growth potential of the cannabis market, TOKE invests in a diversified portfolio of companies involved in various aspects of the industry, from cultivation and processing to retail and pharmaceuticals. The ETF targets approximately 20 to 50 of the top cannabis companies around the world, spanning various market capitalizations. TOKE's investment strategy focuses on identifying companies with strong growth prospects and sound financial fundamentals. By diversifying across multiple companies and geographies, the ETF seeks to mitigate risk and provide investors with a balanced exposure to the cannabis market. The ETF's holdings are regularly reviewed and rebalanced to ensure that the portfolio remains aligned with its investment objectives. TOKE does not offer dividend payouts, reinvesting any earnings to maximize long-term growth. The ETF's expense ratio reflects the costs associated with managing a global portfolio of cannabis companies, including research, trading, and regulatory compliance. TOKE is available to investors through various brokerage platforms and financial advisors.

What Products and Services Does TOKE Offer?

• Invests in a diversified portfolio of cannabis companies.
• Targets approximately 20 to 50 of the top cannabis companies worldwide.
• Provides exposure to the global cannabis industry.
• Spans various market capitalizations.
• Regularly reviews and rebalances its portfolio.
• Seeks to mitigate risk through diversification.

How Does TOKE Make Money?

• Generates revenue through management fees charged to investors.
• Invests in cannabis companies across various sectors of the industry.
• Rebalances portfolio to maintain alignment with investment objectives.

What Industry Does TOKE Operate In?

The asset management industry is evolving rapidly, with increasing demand for specialized ETFs that target specific sectors like cannabis. The global cannabis market is experiencing significant growth, driven by legalization trends and increasing acceptance of cannabis for medical and recreational use. Cambria Cannabis ETF (TOKE) competes with other cannabis-focused ETFs, such as ALIL, DFVE, FTXG, LST, and LTL, each with its own investment strategy and portfolio composition. The ETF's success depends on its ability to identify and capitalize on growth opportunities within the cannabis industry while managing regulatory and competitive risks.

Who Are TOKE's Key Customers?

• Retail investors seeking exposure to the cannabis industry.
• Institutional investors looking for diversified cannabis investments.
• Financial advisors seeking to provide cannabis exposure to their clients.

Cambria Cannabis ETF (TOKE) Valuation Context

Valued at $12.0M, TOKE is classified as a micro-cap stock.

Return on equity for Cambria Cannabis ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. TOKE trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

TOKE Financials

TOKE Latest News

No recent news available for TOKE.

What Investors Ask About Cambria Cannabis ETF (TOKE) — Financial Services

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources